These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 14665869

  • 1. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD, Patel MI, Sheinfeld J.
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
    Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP.
    J Clin Oncol; 2005 Sep 01; 23(25):6149-56. PubMed ID: 16135481
    [Abstract] [Full Text] [Related]

  • 4. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.
    Cancer; 2003 Oct 15; 98(8):1635-42. PubMed ID: 14534879
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB, Nichols CR, Foster RS, Messemer JE, Donohue JP, Einhorn LH.
    J Urol; 1996 Feb 15; 155(2):587-9. PubMed ID: 8558665
    [Abstract] [Full Text] [Related]

  • 8. Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.
    Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP.
    J Urol; 1996 Apr 15; 155(4):1296-8. PubMed ID: 8632558
    [Abstract] [Full Text] [Related]

  • 9. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
    Peterson M, Beck S, Bihrle R, Einhorn L, Foster R.
    BJU Int; 2009 Jul 15; 104(2):176-8. PubMed ID: 19493258
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
    Carver BS, Bianco FJ, Shayegan B, Vickers A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Urol; 2006 Jul 15; 176(1):100-3; discussion 103-4. PubMed ID: 16753380
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Morris MJ, Bosl GJ.
    J Urol; 2000 Mar 15; 163(3):796-801. PubMed ID: 10687980
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
    Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP.
    Urol Clin North Am; 2007 May 15; 34(2):219-25; abstract ix-x. PubMed ID: 17484926
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers].
    Matveev VB, Volkova MI, Cherniev VA, Figurin KM, Mitin AV.
    Urologiia; 2010 May 15; (3):41-7. PubMed ID: 20734877
    [Abstract] [Full Text] [Related]

  • 20. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ, Oosterhuis JW, Marrink J, De Bruin HW, Schraffordt Koops H, Sleijfer DT, Fleuren GJ.
    Oncodev Biol Med; 1983 May 15; 4(4):289-308. PubMed ID: 6188132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.